G511(P) The trends and geographical variations in place of deaths in children and young people with cancer: Population-based study in England 1993–2013

2016 ◽  
Vol 101 (Suppl 1) ◽  
pp. A303.2-A303
Author(s):  
W Gao ◽  
J Verne ◽  
J Peacock ◽  
C Stiller ◽  
C Wells ◽  
...  
2019 ◽  
Vol 22 (3) ◽  
pp. 129-133 ◽  
Author(s):  
Ruth H Jack ◽  
Chris Hollis ◽  
Carol Coupland ◽  
Richard Morriss ◽  
Roger David Knaggs ◽  
...  

IntroductionIncreasing numbers of children and young people (CYP) are receiving prescriptions for antidepressants. This is the protocol of a study aiming to describe the trends and variation in antidepressant prescriptions in CYP in England, and to examine the indications for the prescriptions recorded and whether there was contact with secondary care specialists on or around the time of the first antidepressant prescription.Methods and analysisAll eligible CYP aged between 5 and 17 years in 1998–2017 from the QResearch primary care database will be included. Incidence and prevalence rates of any antidepressant prescription in each year will be calculated. We will examine four different antidepressant classes: selective serotonin reuptake inhibitors, tricyclic and related antidepressants, serotonin and norepinephrine reuptake inhibitors and other antidepressants, as well as for individual drugs. Linked primary and secondary care data (hospital episode statistics) in the year before and up to 6 months after the first antidepressant prescription will be examined for CYP whose first antidepressant prescription was in 2006–2017. Whether there were records of indications and being seen by psychiatric or paediatric specialists will be identified. Trends over time and differences by region, deprivation and ethnicity will be examined using Poisson regression.DiscussionThis large, population-based study will give an up-to-date picture of antidepressant prescribing in CYP and identify any variation. Understanding what indications are recorded when CYP are being prescribed antidepressants, and whether this was done in partnership with secondary care specialists, will provide evidence of whether appropriate guidelines are being followed.


2008 ◽  
Vol 36 (3) ◽  
pp. 198-215 ◽  
Author(s):  
P. L. Appleton ◽  
P. E. Minchom ◽  
N. C. Ellis ◽  
C. E. Elliott ◽  
V. Böll ◽  
...  

2009 ◽  
Vol 59 (566) ◽  
pp. e308-e314 ◽  
Author(s):  
Aurélie Mauerhofer ◽  
André Berchtold ◽  
Pierre-André Michaud ◽  
Joan-Carles Suris

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. 1574-1574
Author(s):  
Abigail Shrader ◽  
Linda Niccolai ◽  
Susan T Mayne ◽  
Daniel DiMaio ◽  
Anees B. Chagpar

1574 Background: Human papilloma virus (HPV) is associated with a number of malignancies. While national guidelines exist for the use of HPV vaccines in men and women up to the age of 26, data are lacking regarding public awareness of these vaccines. Methods: The National Health Interview Survey is conducted annually by the CDC, and is designed to be representative of the US population. Questions regarding the HPV vaccine were fielded in 2010, and formed the basis of this analysis. Results: 9120 men and 10946 women between the ages of 18 and 64 were surveyed. More women than men had heard about the HPV vaccine (68.1% vs. 34.0%, p<0.001), and young people (aged 18-26) were more likely to have heard about the vaccine than their older counterparts (54.3% vs. 50.5%, p=0.002). Factors associated with awareness of HPV vaccines amongst the younger cohort (eligible for the vaccine) are shown below. On multivariate analysis, race, insurance, and education were significant predictors of HPV vaccine awareness. Conclusions: While over half of young people aged 18-26 are aware of the HPV vaccine, racial/ethnic minorities, along with less educated and uninsured populations lag behind their majority counterparts in their awareness of the HPV vaccine. These data should be useful in directing public health educational programs. [Table: see text]


Sign in / Sign up

Export Citation Format

Share Document